Business Wire - Techseriesinsight

October 28, 2024
Business Wire
Biotechnology

ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development

ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies, today announced a partnership...

October 28, 2024
Business Wire
E-Commerce

Shift4 Unveils Global Crypto Payment Capabilities

Shift4 (NYSE: FOUR), the global leader in integrated payments and commerce technology, announces Pay with Crypto, becoming the first major payments company to allow businesses worldwide to accept cryptocurrency...

October 28, 2024
Business Wire
E-Commerce

Network International Signs Strategic Partnership With Ant International to Provide New Payment Solutions to Businesses in MEA, Driving Financial Inclusion

Network International (Network), a leading enabler of digital commerce in the Middle East and Africa (MEA), and leading global digital payment and financial technology provider Ant International, have signed...

October 28, 2024
Business Wire
Biotechnology

GenSight Biologics Announces Publication of Meta-Analyses Showing Better Outcomes for ND4-LHON Patients Treated with LUMEVOQ®

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today...

October 25, 2024
Business Wire
Cloud

Cloud, Mobile, GenAI Driving ADM Growth in Germany

Germany’s growing reliance on cloud computing and mobile applications is driving increased demand for application development and maintenance services, according to a new research report published today by Information...

October 25, 2024
Business Wire
Biotechnology

Modalis Therapeutics has received an Orphan Drug Designation from the U.S. Food and Drug Administration for MDL-101, a treatment for congenital muscular dystrophy type 1A (LAMA2-CMD).

Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883, CEO: Haru Morita), a leading company pioneering treatments for rare genetic diseases using its proprietary CRISPR-based epigenome editing technology, CRISPR-GNDM®, today announced...

October 24, 2024
Business Wire
Biotechnology

ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today presented data from the ongoing global Phase 1a/1b study of ZL-1310, a potential best-in-class next-generation antibody-drug conjugate (ADC), at the EORTC-NCI-AACR...

October 24, 2024
Business Wire
Artificial Intelligence

The Swiss Innovation Agency Funds LatticeFlow AI to Build First Platform Linking AI Governance and Technical Evaluations

LatticeFlow AI, a Swiss leader in trustworthy, safe, and compliant AI, announced today that it has secured about USD 3M funding from the Swiss Innovation Agency (Innosuisse) to advance...

October 24, 2024
Business Wire
Joint Ventures

CPP Investments Partners with Kennedy Wilson to Launch New UK Single-Family Rental Housing Joint Venture Targeting £1 Billion in Real Estate

Canada Pension Plan Investment Board (CPP Investments) has partnered with global real estate investment company Kennedy Wilson (NYSE:KW) to launch a new single-family rental housing joint venture (“the JV”)...

October 24, 2024
Business Wire
Networking

Hytera’s 5G Body Camera to Revolutionize Digital Evidence Acquisition and Management

Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and solutions, has unveiled its latest innovations in body cameras with the launch of two new models: SC780...